Vallourec S.A. (VLOUF)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,578	3,921	3,561	3,000	2,291	374
Market Cap Growth	19.81%	10.11%	18.73%	30.92%	512.34%	-74.07%
Enterprise Value	4,897	4,258	4,506	4,725	3,525	3,803
Last Close Price	19.50	15.34	14.26	11.82	8.71	10.19
PE Ratio	10.78	8.38	6.50	-	50.94	-
PS Ratio	1.02	0.94	0.63	0.57	0.59	0.09
PB Ratio	1.80	1.46	1.45	1.67	1.11	2.29
P/TBV Ratio	1.94	1.55	1.55	1.79	1.20	-
P/FCF Ratio	10.39	11.80	6.68	-	-	-
P/OCF Ratio	7.23	7.77	4.64	-	-	11.21
EV/Sales Ratio	1.12	1.02	0.80	0.91	0.90	0.96
EV/EBITDA Ratio	5.63	5.16	3.49	6.32	6.55	13.79
EV/EBIT Ratio	7.72	6.84	4.13	9.07	10.74	-
EV/FCF Ratio	11.12	12.81	8.45	-	-	-
Debt / Equity Ratio	0.46	0.45	0.69	1.04	0.91	27.83
Debt / EBITDA Ratio	1.32	1.42	1.28	2.45	3.35	14.63
Debt / FCF Ratio	2.66	3.65	3.17	-	-	-
Asset Turnover	0.75	0.72	0.92	0.97	0.70	0.53
Inventory Turnover	2.29	2.36	2.76	3.27	3.10	3.19
Quick Ratio	0.95	1.24	1.09	0.78	1.06	0.73
Current Ratio	2.09	2.14	2.00	1.64	2.05	1.06
Return on Equity (ROE)	17.01%	19.60%	26.80%	-20.82%	3.24%	-125.69%
Return on Assets (ROA)	6.81%	6.69%	11.16%	6.03%	3.68%	-0.14%
Return on Capital (ROIC)	10.35%	9.99%	17.19%	8.85%	4.94%	-0.18%
Return on Capital Employed (ROCE)	15.70%	14.90%	24.00%	13.70%	8.10%	-
Earnings Yield	9.28%	11.94%	15.39%	-13.05%	1.96%	-394.32%
FCF Yield	9.62%	8.47%	14.97%	-7.68%	-14.07%	-36.28%
Dividend Yield	8.68%	10.13%	-	-	-	-
Buyback Yield / Dilution	1.54%	1.76%	-6.39%	-90.98%	-949.64%	-0.05%
Total Shareholder Return	10.22%	11.88%	-6.39%	-90.98%	-949.64%	-0.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.